Pulmatrix (PULM) Competitors

Pulmatrix (NASDAQ:PULM) and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations, community ranking and institutional ownership.

Does the media prefer PULM or IVVD?

In the previous week, Invivyd had 8 more articles in the media than Pulmatrix. MarketBeat recorded 8 mentions for Invivyd and 0 mentions for Pulmatrix. Pulmatrix's average media sentiment score of 1.44 beat Invivyd's score of 0.56 indicating that Pulmatrix is being referred to more favorably in the media.

Company	Overall Sentiment
Pulmatrix	Positive
Invivyd	Positive

Is PULM or IVVD more profitable?

Invivyd has a net margin of 0.00% compared to Pulmatrix's net margin of -96.51%. Pulmatrix's return on equity of -45.97% beat Invivyd's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmatrix	-96.51%	-45.97%	-30.72%
Invivyd	N/A	-155.33%	-114.88%

Do analysts rate PULM or IVVD?

Invivyd has a consensus price target of $7.89, suggesting a potential upside of 669.51%. Given Invivyd's stronger consensus rating and higher possible upside, analysts clearly believe Invivyd is more favorable than Pulmatrix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmatrix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Invivyd	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Which has preferable valuation & earnings, PULM or IVVD?

Pulmatrix has higher earnings, but lower revenue than Invivyd. Pulmatrix is trading at a lower price-to-earnings ratio than Invivyd, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmatrix	$10.01M	2.69	-$14.12M	-$2.64	-2.79
Invivyd	$11.56M	10.60	-$198.64M	-$1.96	-0.52

Do institutionals & insiders hold more shares of PULM or IVVD?

11.8% of Pulmatrix shares are owned by institutional investors. Comparatively, 70.4% of Invivyd shares are owned by institutional investors. 0.6% of Pulmatrix shares are owned by insiders. Comparatively, 17.9% of Invivyd shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer PULM or IVVD?

Pulmatrix received 174 more outperform votes than Invivyd when rated by MarketBeat users. However, 84.62% of users gave Invivyd an outperform vote while only 48.28% of users gave Pulmatrix an outperform vote.

Company	Underperform	Outperform
Pulmatrix	Outperform Votes 196 48.28%	Underperform Votes 210 51.72%
Invivyd	Outperform Votes 22 84.62%	Underperform Votes 4 15.38%

Which has more volatility & risk, PULM or IVVD?

Pulmatrix has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Invivyd has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500.

Summary

Invivyd beats Pulmatrix on 13 of the 19 factors compared between the two stocks.